Information Provided By: 
Fly News Breaks for June 29, 2015
PETX
Jun 29, 2015 | 08:22 EDT
William Blair increased its probability of success for AT-002 in dogs to 95% after Aratana Therapeutics announced results for the drug after the bell on Friday. The firm also noted that the company’s third small molecule candidate, AT-003 to treat post-surgical pain in dogs, is set to report top-line results in the second half of next month. William Blair keeps an Outperform rating on Aratana shares.
News For PETX From the Last 2 Days
There are no results for your query PETX
